Effect of glucagon-like peptide-1 (GLP-1) agonists on the example of semaglutide on the cardiovascular system and their role in the treatment of obesity.

• Glavni autori: Kamil Pondel (Autor), Kinga Kawałko (Autor), Krzysztof Bielewicz (Autor), Anna Chmura (Autor), Anna Karaś (Autor)
• Format: Knjiga
• Izdano: Kazimierz Wielki University, 2022-08-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Obesity nowadays affects an increasing number of people. We can talk about it when the patient's BMI is ≥ 30.0 kg/m² (BMI 25.0-29.9 kg/m² - overweight). While obesity in itself may not be a problem for people suffering from it, its complications can be global and sometimes pose a serious threat...